North Sichuan Medical University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Nanchong China (1951)

Organization Overview

First Clinical Trial
2008
NCT04421274
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Affiliated Hospital of North Sichuan Medical College

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Esophageal Neoplasms (Phase 2)

Infarction (Phase 3)

Lung Neoplasms (Phase 4)

Myocardial Infarction (Phase 3)

Nasopharyngeal Carcinoma (Phase 2)

Nausea (Phase 4)

ST Elevation Myocardial Infarction (Phase 3)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 22